Literature DB >> 23148289

Low bone mineral density, regardless of HIV status, in men who have sex with men.

Marlous L Grijsen1, Saskia M E Vrouenraets, Ferdinand W N M Wit, Ineke G Stolte, Maria Prins, Paul Lips, Peter Reiss, Jan M Prins.   

Abstract

A high prevalence of low bone mineral density (BMD) has been reported among men with primary or chronic human immunodeficiency virus (HIV) infection. To gain further insight into the contribution of HIV infection, we compared the BMD of 41 men who have sex with men (MSM) with primary HIV infection, 106 MSM with chronic HIV infection, and a control group of 30 MSM without HIV infection. Low BMD, defined as a z score of ≥ 2.0 SDs below the mean at the lumbar spine or hip, was highly prevalent in all 3 groups. In the multivariate analyses, HIV infection was not associated with BMD, suggesting that low BMD previously reported in HIV-infected MSM may predate HIV acquisition.

Entities:  

Mesh:

Year:  2012        PMID: 23148289     DOI: 10.1093/infdis/jis687

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Kathleen Mulligan; David V Glidden; Peter L Anderson; Albert Liu; Vanessa McMahan; Pedro Gonzales; Maria Esther Ramirez-Cardich; Sirianong Namwongprom; Piotr Chodacki; Laura Maria Carvalo de Mendonca; Furong Wang; Javier R Lama; Suwat Chariyalertsak; Juan Vicente Guanira; Susan Buchbinder; Linda-Gail Bekker; Mauro Schechter; Valdilea G Veloso; Robert M Grant
Journal:  Clin Infect Dis       Date:  2015-04-23       Impact factor: 9.079

2.  An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.

Authors:  Sybil G Hosek; Bret Rudy; Raphael Landovitz; Bill Kapogiannis; George Siberry; Brandy Rutledge; Nancy Liu; Jennifer Brothers; Kathleen Mulligan; Gregory Zimet; Michelle Lally; Kenneth H Mayer; Peter Anderson; Jennifer Kiser; James F Rooney; Craig M Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

Review 3.  Bone health in HIV and hepatitis B or C infections.

Authors:  Emmanuel Biver; Alexandra Calmy; René Rizzoli
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-10-07       Impact factor: 5.346

4.  Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.

Authors:  Peter L Havens; Suzanne E Perumean-Chaney; Amit Patki; Stacey S Cofield; Craig M Wilson; Nancy Liu; Peter L Anderson; Raphael J Landovitz; Bill G Kapogiannis; Sybil G Hosek; Kathleen Mulligan
Journal:  Clin Infect Dis       Date:  2020-02-03       Impact factor: 9.079

Review 5.  Bone loss in HIV: a contemporary review.

Authors:  Corrilynn O Hileman; Allison Ross Eckard; Grace A McComsey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-12       Impact factor: 3.243

Review 6.  People with HIV infection had lower bone mineral density and increased fracture risk: a meta-analysis.

Authors:  Chao-Jui Chang; Yi-Lin Chan; Iqbal Pramukti; Nai-Ying Ko; Ta-Wei Tai
Journal:  Arch Osteoporos       Date:  2021-02-27       Impact factor: 2.617

7.  Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.

Authors:  Mariska C Vlot; Marlous L Grijsen; Jan M Prins; Renate T de Jongh; Robert de Jonge; Martin den Heijer; Annemieke C Heijboer
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

8.  Effect of Testosterone Use on Bone Mineral Density in HIV-Infected Men.

Authors:  Philip M Grant; Xiuhong Li; Lisa P Jacobson; Frank J Palella; Lawrence A Kingsley; Joseph B Margolick; Adrian S Dobs; Jordan E Lake; Keri N Althoff; Todd T Brown
Journal:  AIDS Res Hum Retroviruses       Date:  2018-11-01       Impact factor: 1.723

9.  High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy.

Authors:  Pyoeng Gyun Choe; Hyung Jin Choi; Nak-Hyun Kim; Wan Beom Park; Kyoung-Ho Song; Ji Hwan Bang; Eu Suk Kim; Sang Won Park; Hong Bin Kim; Myoung-don Oh; Nam Joong Kim
Journal:  J Int AIDS Soc       Date:  2014-01-09       Impact factor: 5.396

Review 10.  Influence of HIV Infection and Antiretroviral Therapy on Bone Homeostasis.

Authors:  María Victoria Delpino; Jorge Quarleri
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.